[ad_1]
This came as the Coalition for Epidemic Preparedness Innovations (CEPI) called on international donors to support a five-year strategy costing $ 3.5 billion to address the risks of any pandemic in the future.
Richard Hatchett, executive director of the coalition, said at an online event that while Covid-19 has claimed nearly 2.5 million lives so far, "Next time we may not be so lucky".
و .ضاف "The Covid-19 pandemic is not the first pandemic of the 21st century, and if we do not act now, we can be sure that it will not be the last. There is absolutely nothing to stop the next virus that may emerge from being much more deadly.".
He said governments, global health organizations and other partners must now make vital investments in global health security and leverage "The Revolution in Vaccine Science Powered by COVID-19".
He continued saying "Every day we can shorten each step of the process should be shortened".
To reduce the vaccine development period to 100 days, the coalition said, researchers and drug companies will need to exploit the potential of so-called rapid-response software technology, like the one that Pfizer-Biontech and Moderna used to develop vaccines.
It will also require working with global regulators to simplify requirements for vaccine approval and link manufacturing facilities to enable rapid vaccine production.
“>
This came as the Coalition for Epidemic Preparedness Innovations (CEPI) called on international donors to support a five-year strategy costing $ 3.5 billion to address the risks of any pandemic in the future.
Richard Hatchett, executive director of the coalition, said at an online event that while Covid-19 has claimed nearly 2.5 million lives so far, “we may not be so lucky next time.”
“The Covid-19 pandemic is not the first pandemic of the 21st century, and if we do not act now, we can be sure that it will not be the last. There is absolutely nothing to prevent the next virus that may emerge from being much more deadly.” .
He said governments, global health organizations and other partners must now make vital investments in global health security and take advantage of the “revolution in vaccine science driven by COVID-19.”
“We must shorten each day, what we can shorten at each step of the process,” he said.
To reduce the vaccine development period to 100 days, the coalition said, researchers and drug companies will need to exploit the potential of so-called rapid-response software technology, like the one that Pfizer-Biontech and Moderna used to develop vaccines.
It will also require working with global regulators to simplify requirements for vaccine approval and link manufacturing facilities to enable rapid vaccine production.
[ad_2]
